IDEXX Laboratories (Germany) Analysis

IDEXX Stock Analysis Notes

About 95.0% of the company shares are owned by institutional investors. The company recorded earning per share (EPS) of 11.05. IDEXX Laboratories had not issued any dividends in recent years. The entity had 2:1 split on the 16th of June 2015. IDEXX Laboratories, Inc., together with its subsidiaries, develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. IDEXX Laboratories, Inc. was founded in 1983 and is headquartered in Westbrook, Maine. IDEXX Laboratories operates under Diagnostics Research classification in Germany and is traded on Frankfurt Stock Exchange. It employs 8000 people. To learn more about IDEXX Laboratories call Jonathan Mazelsky at 207 556 0300 or check out https://www.idexx.com.

IDEXX Laboratories Investment Alerts

IDEXX Market Capitalization

The company currently falls under 'Large-Cap' category with a current market capitalization of 42.82 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate IDEXX Laboratories's market, we take the total number of its shares issued and multiply it by IDEXX Laboratories's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

IDEXX Profitablity

The company has Profit Margin (PM) of 0.25 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.29 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.29.

Management Efficiency

IDEXX Laboratories has return on total asset (ROA) of 0.2559 % which means that it generated a profit of $0.2559 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.662 %, meaning that it generated $0.662 on every $100 dollars invested by stockholders. IDEXX Laboratories' management efficiency ratios could be used to measure how well IDEXX Laboratories manages its routine affairs as well as how well it operates its assets and liabilities. At this time, IDEXX Laboratories' Other Current Assets are most likely to decrease significantly in the upcoming years. The IDEXX Laboratories' current Non Currrent Assets Other is estimated to increase to about 359.6 M, while Total Current Assets are projected to decrease to roughly 1.1 B.

Technical Drivers

As of the 21st of February, IDEXX Laboratories retains the Market Risk Adjusted Performance of (0.46), risk adjusted performance of (0.06), and Coefficient Of Variation of (1,106). IDEXX Laboratories technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices. Please check out IDEXX Laboratories variance, treynor ratio, and the relationship between the standard deviation and information ratio to decide if IDEXX Laboratories is priced more or less accurately, providing market reflects its last-minute price of 535.4 per share.

IDEXX Laboratories Price Movement Analysis

IDEXX Laboratories Outstanding Bonds

IDEXX Laboratories Predictive Daily Indicators

IDEXX Laboratories Forecast Models

IDEXX Laboratories' time-series forecasting models are one of many IDEXX Laboratories' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary IDEXX Laboratories' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

IDEXX Laboratories Debt to Cash Allocation

IDEXX Laboratories has accumulated 417.79 M in total debt. IDEXX Laboratories has a current ratio of 0.99, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist IDEXX Laboratories until it has trouble settling it off, either with new capital or with free cash flow. So, IDEXX Laboratories' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like IDEXX Laboratories sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for IDEXX to invest in growth at high rates of return. When we think about IDEXX Laboratories' use of debt, we should always consider it together with cash and equity.

IDEXX Laboratories Total Assets Over Time

IDEXX Laboratories Assets Financed by Debt

Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the IDEXX Laboratories' operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of IDEXX Laboratories, which in turn will lower the firm's financial flexibility.

IDEXX Laboratories Corporate Bonds Issued

IDEXX Long Term Debt

Stock analysis is the technique used by a trader or investor to examine and evaluate how IDEXX Laboratories prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling IDEXX shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as IDEXX Laboratories. By using and applying IDEXX Stock analysis, traders can create a robust methodology for identifying IDEXX entry and exit points for their positions.

When running IDEXX Laboratories' price analysis, check to measure IDEXX Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy IDEXX Laboratories is operating at the current time. Most of IDEXX Laboratories' value examination focuses on studying past and present price action to predict the probability of IDEXX Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move IDEXX Laboratories' price. Additionally, you may evaluate how the addition of IDEXX Laboratories to your portfolios can decrease your overall portfolio volatility.